With this partnership, Inflectra can deliver their cloud-based apps as “validated” apps that meet FDA’s 21 CFR Part 11 as well as predicate regulations. xLM’s Continuous Validation Service handles all validation tasks from initial validation, upgrade/patch validation, new release validation and subsequent “continuous” validation. With xLM’s service, customers can view the “validation dashboard” of their instance in real-time.
“This partnership brings cost efficient validation that will also save time,” said Adam Sandman, Director of Technology at Inflectra. “Our customers will have access to all our apps that are delivered “validated” with real-time access to its “validation health”. Now our customers will be able to focus on using our apps while xLM’s service handles all the validation tasks leveraging their continuous validation platform.”
“Continuous validation is providing documented evidence to certify that any Inflectra app not only met the pre-established acceptance criteria but “continuous” to meet thus mitigating the risk of unknown changes.” said Nagesh Nama, Chief Quality Officer (CQO) of xLM, LLC.
Inflectra is dedicated to helping our customers effectively and affordably manage their software development lifecycle. We are proud to be able to help software teams decrease their time to market and increase the return on investment.
Our strong focus on providing an excellent customer experience helps us attract and retain customers of all sizes, across a broad range of markets and industries—from large corporations to small businesses, government agencies to individual developers, and professional services firms.
To learn more about Inflectra, visit us at www.inflectra.com or call 202-558-6885.
About xLM, LLC
xLM, LLC provides innovative continuous validation services by partnering with various cloud companies that cater to Life Science customers worldwide. xLM, LLC is a subsidiary of ValiMation, Inc. which was founded in 1996 and headquartered in Wayne, PA. xLM Managed Validation Service meets or exceeds GxP requirements established by the FDA, EMA.